Effectors of inflammation in actinic prurigo.
BACKGROUND
Actinic prurigo is a specific familial photodermatosis of uncertain pathogenesis.


OBJECTIVE
Our purpose was to investigate the immunohistologic presentation of actinic prurigo to explore the involved pathomechanisms.


METHODS
The present immunohistochemical study was performed on biopsy specimens from 20 Mexican patients presenting with a severe and perennial form of the disease.


RESULTS
The dense inflammatory infiltrate was composed predominantly of helper T type 1 lymphocytes admixed with scattered B-cell lymphoid follicles and numerous dermal dendrocytes. Keratinocytes contained abundant tumor necrosis factor-alpha and calprotectin.


CONCLUSIONS
In subjects genetically predisposed to actinic prurigo, ultraviolet light may trigger excessive tumor necrosis factor-alpha production by keratinocytes whose sustained release in turn exerts its proinflammatory activity and deleterious epidermal effects. Such a cascade of events is in line with the therapeutic benefit already reported when thalidomide is used to treat actinic prurigo.
Arrese
J E
JE
Department of Dermatopathology, University Medical Center of Liège, Belgium.
Dominguez-Soto
L
L
Hojyo-Tomoka
M T
MT
Vega-Memije
E
E
Cortés-Franco
R
R
Guevara
E
E
Piérard
G E
GE
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D007150:Immunohistochemistry; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007249:Inflammation; D015603:Keratinocytes; D008297:Male; D008875:Middle Aged; D010787:Photosensitivity Disorders / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D011536:Prurigo / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D012621:Seasons; D013792:Thalidomide / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*; D014466:Ultraviolet Rays
D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D013792:Thalidomide